v3.24.2.u1
Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash Flows from Operating Activities    
Net loss $ (13,941,397) $ (26,856,837)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,635,897 2,935,067
Amortization of intangible asset   727,500
Noncash lease expense 184,101 218,551
Stock-based compensation 533,086 1,434,527
Change in fair value of contingent consideration   109,500
Change in fair value of contingent earn-out receivable, related party (1,000,000)  
Change in fair value of non-convertible promissory note, related party 10,000  
Change in fair value of convertible promissory note, related party 104,250  
Gain on partial extinguishment (170,000)  
Unrealized loss on investments (995) (63,321)
Deferred tax liability   (571,120)
Accounts receivable (1,945,104) (179,321)
Other assets   (193,124)
Prepaid expenses and other current assets 258,680 217,463
Inventory 838,331  
Grant receivable   1,524,522
Right-of-use assets   386,336
Deposits (26,622) 60,376
Accounts payable (313,048) (2,101,841)
Deferred revenue 34,298 1,116,216
Accrued expenses and other liabilities 575,902 (767,835)
Net Cash Used In Operating Activities (11,222,621) (22,003,341)
Cash Flows from Investing Activities    
Purchase of short-term investments (682,648) (340,380)
Sale of intellectual property license 1,000,000  
Sale of short-term investments 2,855,775 23,514,465
Purchases of property and equipment (695,700) (1,036,623)
Disposal of property and equipment 564,692 184,528
Net Cash Provided by Investing Activities 3,042,119 22,321,990
Cash Flows from Financing Activities    
Proceeds from issuance of convertible promissory note, related party 2,253,750  
Proceeds from issuance of non-convertible promissory note, related party 750,000  
Proceeds from issuance of common stock 7,631,381  
Proceeds from issuance of common stock through at-the-market 8,399  
Proceeds from issuance of common stock upon exercise of warrants 178,424  
Proceeds from issuance of common stock under ESPP 12,904  
Stock issuance costs (894,868)  
Repayments of principal under finance lease (469,299) (2,915,654)
Net Cash Provided by (Used In) Financing Activities 9,470,691 (2,915,654)
Effect of exchange rate changes on cash and cash equivalents (3,002) (865)
Net Increase (Decrease) in Cash and Cash Equivalents 1,287,187 (2,597,870)
Cash and Cash Equivalents - Beginning of the Period 184,925 8,434,554
Cash and Cash Equivalents - End of the Period 1,472,112 5,836,684
Supplemental Disclosure for Cash Flow Information:    
Right-of-use assets surrendered upon financing lease modifications   (3,092,408)
Right-of-use assets surrendered upon operating lease modifications $ (85,226) 7,789,655
Supplemental disclosure of non-cash investing and financing activities:    
Purchases of property and equipment included in accounts payable   $ 373,127

Source

HTML PDF
ZIP